Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

FDA accepts Marathon’s Duchenne drug for priority review

August 11, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals

Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …
News
chemo-web

Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug

August 11, 2016 Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol

Heron Therapeutics has announced that it has received US Food and Drug Administration (FDA) approval for Sustol (granisetron) for the …
News
chronos_therapeutics

Chronos Therapetics strengthens management with two new vice presidents

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …
Appointment
josh-smiley

New senior VP, finance at Eli Lilly

August 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …
Appointment
china-pharmaceutical-industry

New Agilent expansion will ‘more than double’ nucleic acid API manufacture

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide

Agilent Technologies is set to expand its pharmaceutical manufacturing operations with a 20-acre facility in Weld County, Colorado. The facility …
News
lilly_corporate_hq

Interim analysis fails to show benefits for Lilly’s abemaciclib in advanced breast cancer

August 10, 2016 Research and Development Eli Lilly, abemaciclib, breast cancer

Eli Lilly has announced that, after a pre-planned interim analysis for their Phase III MONARCH2 trial, investigators have decided to …
News
shutterstock_138095450

Valeant stock rises despite weak Q2 results

August 10, 2016 Research and Development, Sales and Marketing Valeant, financial results

Valeant Pharmaceuticals’ share price in pre-market trading has risen 7.44% to $24.12 in the wake of its Q2 results announcement. …
News
biogen_austria_238

Biogen names haemophilia spin-off Bioverativ

August 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, bioverativ

Biogen has announced that Bioverativ will be the name of the standalone spin-off of its haemophilia and other blood disorders …
News

Experimental stem cell treatment shows promise in rheumatoid arthritis

August 10, 2016 Research and Development Mesoblast, rheumatoid arthritis, stem cell treatment

Mesoblast has announced results from a Phase II clinical trial evaluating MPC-300-IV in patients with biologic refractory rheumatoid arthritis (RA) …
News
takeda_tokyo_hq

Old CDF drug not recommended in initial NICE guidance due to lack of evidence

August 10, 2016 Research and Development, Sales and Marketing Adcetris, Cancer Drugs Fund, NICE, Takeda, hodgkin's lymphoma

The National Institute for Health and Care Excellence (NICE) has published draft guidance not recommending Takeda’s Adectris (brentuximab vedotin), despite …
News
pharma_pill_manufacturing

Helsinn and MEI Pharma join forces to develop leukaemia drug Pracinostat

August 9, 2016 Manufacturing and Production, Research and Development Helsinn, MEI Pharma, Pracinostat, chronic myeloid leukaemia

Swiss pharmaceutical group Helsinn has entered an agreement with MEI Pharma over the licensing, development and commercialisation of Pracinostat (SB939) …
News
ema_inside

New therapy wins EMA orphan drug designation for ALS

August 9, 2016 Manufacturing and Production, Research and Development EMA, Ice Bucket Challenge, ab science, als, masitinib, oprhan drug designation

French pharma company AB Science has announced that the European Medicines Agency has granted orphan drug status to masitinib for …
News
merckincweb2

FDA approves MSD’s Keytruda for head and neck cancer treatment

August 8, 2016 Manufacturing and Production, Research and Development Cancer, FDA, MSD, keytruda

The US Food and Drug Administration (FDA) has approved MSD’s Keytruda (pembrolizumab) for treatment of recurrent or metastatic head and …
News
bms

SMC reverses decision on Opdivo in advanced skin cancer

August 8, 2016 Manufacturing and Production, Research and Development SMC, Scottish Medicines Consortium, melanoma, opdivo, skin cancer

The Scottish Medicines Consortium (SMC) has reversed an earlier decision for Bristol-Myers Squibb’s Opdivo (nivolumab) and has now approved recommended …
News

Apellis Pharmaceuticals appoints Dr Robert Kim as CMO

August 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apellis, CMO, GSK, Novartis, appointment

Clinical stage complement immunotherapy company Apellis Pharmaceuticals has named its new chief medical officer as Dr Robert Kim. Kim’s primary …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026